Large Pharma With Big-Time Growth
While large pharmaceutical companies continue to fight the patent cliff, Gilead Sciences, Inc. (NASDAQ:GILD) continues to prove that it’s one of the best in the space. The company announced earnings, beating both top and bottom line expectations, and growing revenue by 18% year-over-year. Its new product Comlera grew sales from under $20 million last year to $117.8 million this quarter.
Some have expressed concerns that the stock might be too expensive compared to others in the industry. However, keep in mind, other large pharma companies are seeing flat or declining sales due to the patent cliff. This is a company with a strong pipeline, growing products, and industry-best efficiency. Therefore, I say to definitely buy this stock.
It’s always companies such as Apple Inc. (NASDAQ:AAPL), Caterpillar Inc. (NYSE:CAT), or on Monday, Yum! and Baidu that capture the attention of the market. These companies affect market direction the following day, yet the four companies I highlighted above show bright spots for the earning season. I suggest you perform additional due diligence, assess the valuation of these companies, and then determine if any fit into your portfolio.
The article Four Stocks with Strong After-Hour Earnings to Move on Tuesday originally appeared on Fool.com and is written by Brian Nichols.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.